Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2003
12/18/2003CA2488682A1 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
12/18/2003CA2488633A1 Device for multiple simultaneous gene transfer
12/18/2003CA2488575A1 Three dimensional vaginal tissue model containing immune cells
12/18/2003CA2488429A1 Generation of neural stem cells from undifferentiated human embryonic stem cells
12/18/2003CA2488425A1 Methods of regulating differentiation in stem cells
12/18/2003CA2488346A1 Methods and compositions for the repair and/or regeneration of damaged myocardium
12/18/2003CA2488328A1 Retrons for gene targeting
12/18/2003CA2488249A1 Spliceosome mediated rna trans-splicing in stem cells
12/18/2003CA2488246A1 Spliceosome mediated rna trans-splicing and correction of factor viii genetic defects using spliceosome mediated rna trans spling
12/18/2003CA2488059A1 Non-polymeric hematopoietic cell clots for delivery of active agents
12/18/2003CA2488057A1 Hair follicle mesenchymal stem cells and use thereof
12/18/2003CA2487943A1 Methods of diagnosing & treating diabetes and insulin resistance
12/18/2003CA2487924A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
12/18/2003CA2487831A1 Immunogenic compositions
12/18/2003CA2487826A1 Sterilization, stabilization and preservation of functional biologics
12/18/2003CA2487077A1 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
12/18/2003CA2486362A1 Novel recombinant anticoagulant proteins
12/18/2003CA2486270A1 Vegfr modulating agents and methods for liver growth and liver protection
12/18/2003CA2479072A1 Assay device that analyzes the absorption, metabolism, permeability and/or toxicity of a candidate compound
12/17/2003EP1371664A1 Wti modified peptide
12/17/2003EP1371660A1 Vaccine
12/17/2003EP1370696A2 Expression profiles and methods of use
12/17/2003EP1370684A2 Polynucleotides related to colon cancer
12/17/2003EP1370683A2 mRNA AMPLIFICATION
12/17/2003EP1370676A2 Mouse cytokine receptor
12/17/2003EP1370674A2 Enzymes having alpha amylase activity and methods of use thereof
12/17/2003EP1370666A2 Genetic immunisation against cervical carcinoma
12/17/2003EP1370662A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor
12/17/2003EP1370661A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370655A2 Secreted human proteins
12/17/2003EP1370654A2 Chimpanzee erythropoietin (chepo) immunoadhesins
12/17/2003EP1370649A1 Protein c variants
12/17/2003EP1370648A2 Alpha-amylase mutants with altered properties
12/17/2003EP1370644A2 Materials and methods for the induction of premature chromosome condensation
12/17/2003EP1370642A2 Pluripotent adult stem cells derived from regenerative tissue
12/17/2003EP1370641A2 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia
12/17/2003EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89)
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370585A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370583A1 Polypeptides and nucleic acids for bolekine
12/17/2003EP1370580A2 A new essential downstream component of the wingless signalling pathway
12/17/2003EP1370579A1 Matrix gene expression in chondrogenesis
12/17/2003EP1370194A2 Composition and methods fro the production of biological tissues and tissue constructs
12/17/2003EP1370134A2 Methods and compositions for cryopreservation of dissociated primary animal cells
12/17/2003EP1007074B1 Hypothalamus-specific polypeptides
12/17/2003EP0954580B1 Human sdf-5 protein and compositions
12/17/2003EP0835310B1 Regulatory elements conferring tapetum specificity
12/17/2003EP0792363B1 Novel pesticidal proteins and strains
12/17/2003EP0706570B1 Plants having modified response to ethylene
12/17/2003EP0650523B1 RECOMBINANT CDw52 ANTIGEN
12/17/2003EP0571387B1 A non-mitogenic competitive hgf antagonist
12/17/2003EP0552142B2 T cell receptor peptides as therapeutics for autoimmune and malignant disease
12/17/2003CN1462309A Codon-optimized papilloma virus sequences
12/17/2003CN1462195A Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same
12/17/2003CN1462192A Blood cell production via activation of hemeglobin scavenger receptor
12/17/2003CN1131315C Prodn. of trehalos in plant
12/16/2003US6664441 Compound assay
12/16/2003US6664387 Expression cassette and plasmid for strong constitutive gene expression and the use thereof
12/16/2003US6664385 Kidney injury-related molecules
12/16/2003US6664376 Chimeric polypeptide molecules
12/16/2003US6664375 Nucleotide sequences coding binding protein for use in the treatment of alzheimer's disease and nervous system disorders
12/16/2003US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
12/16/2003US6664106 Use in preparing cell libraries and substances to modulate cell proliferation, DNA synthesis & telomerase activity, for identifying environmentally harmful materials, for culturing microorganisms, for optimizing nutritional requirements
12/16/2003US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
12/16/2003US6664098 Cellular differentiation and proliferation; ligands, membrane receptors; antigrowth agents; use of human Notch ligand, human Delta molecule, in development of drug candidates for differential regulation of undifferentiated cells
12/16/2003US6664092 Nucleic acid sequences; amino acid sequences; vectors; host cells; genetic engineering; Aspergillus oryzae; use in the production of protein hydrolysates having desirable organoleptic properties and high degrees of hydrolysis
12/16/2003US6664090 Carboxylesterase nucleic acid molecules, proteins and uses thereof
12/16/2003US6664088 Production of vanillin
12/16/2003US6664077 DNA encoding ACPL
12/16/2003US6664068 Antibodies, antiapoptotic agents
12/16/2003US6664048 Combination of selection steps used to detect clones that express interacting molecules from false positive clones.
12/16/2003US6664040 Complexing to polypeptides; antiproliferation agent
12/16/2003US6663872 Immune response
12/16/2003US6663870 Methods for promoting growth of bone using zvegf3
12/16/2003US6663868 Heat shock protein-based vaccines and immunotherapies
12/16/2003US6663867 Administering to a patient a hybrid protein comprising two different coexpressed amino acid sequences forming heterodimer, each comprising an amino acid sequence of tumor nacrosis factor binding protein and a subunit of hCG, FSG, LH
12/16/2003US6662805 Method for composite cell-based implants
12/16/2003CA2251983C Regeneration and augmentation of bone using mesenchymal stem cells
12/16/2003CA2134751C Monoclonal antibodies and their use
12/16/2003CA2043527C Biocompatible perforated membranes, processes for their preparation, and uses thereof
12/14/2003CA2430259A1 Vaccine
12/11/2003WO2003102595A1 Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
12/11/2003WO2003102584A2 Semaphorin-like proteins and methods of using same
12/11/2003WO2003102245A1 Antisense modulation of beta-site app-cleaving enzyme 2 expression
12/11/2003WO2003102215A2 Methods of identifying and isolating stem cells and cancer stem cells
12/11/2003WO2003102213A2 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants
12/11/2003WO2003102197A1 Transgenic plants with controlled distribution of a trait to progeny
12/11/2003WO2003102192A1 Methods of purification of cytochrome p450 proteins and of their crystallizing
12/11/2003WO2003102191A1 Immunogenic sequences
12/11/2003WO2003102189A1 Allergen from mugwort pollen
12/11/2003WO2003102188A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof
12/11/2003WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
12/11/2003WO2003102184A1 Methods, compositions and kits for cell separation
12/11/2003WO2003102177A1 METHOD OF SCREENING COMPOUND AFFECTING AMYLOID β PRODUCTION
12/11/2003WO2003102176A1 Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment
12/11/2003WO2003102174A2 Modified phytases
12/11/2003WO2003102171A1 Expansion and transdifferentiation of human acinar cells
12/11/2003WO2003102166A2 Novel flavivirus antigens
1 ... 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 ... 1827